Steris plc logo

Steris plc (2TG)

Market Open
27 Feb, 07:01
XBER XBER
216. 00
0
0%
21B Market Cap
39.65 P/E Ratio
2.08% Div Yield
0 Volume
8.66 Eps
216
Previous Close
Day Range
216 216
Year Range
185 234
Want to track 2TG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
STE earnings report is expected in 70 days (12 May 2026)

Summary

2TG trading today higher at €216, an increase of 0% from yesterday's close, completing a monthly increase of 0% or €0. Over the past 12 months, 2TG stock gained 0%.
2TG pays dividends to its shareholders, with the most recent payment made on Dec 18, 2025. The next announced payment will be in In 2 weeks on Mar 19, 2026 for a total of €0.63.
The last earnings report, released on Feb 04, 2026, missed the consensus estimates by -2.53%. On average, the company has fell short of earnings expectations by -0.81%, based on the last three reports. The next scheduled earnings report is due on May 12, 2026.
Steris plc has completed 2 stock splits, with the recent split occurring on Aug 25, 1998.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NYSE (USD).

2TG Chart

Steris (STE) International Revenue Performance Explored

Steris (STE) International Revenue Performance Explored

Explore Steris' (STE) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks | 3 weeks ago
STERIS: A Bump In The Road For A Reliable Name

STERIS: A Bump In The Road For A Reliable Name

STERIS offers a resilient, high-quality business model with some premium valuation, benefiting from hard-to-replicate sterilization networks and stable healthcare procedure volumes. Recent quarterly results included on-target 8% organic revenue growth but margin pressure from tariffs, with management raising tariff impact guidance by $10 million. STE stands to gain from stricter ethylene oxide (EtO) regulations, as compliance costs favor large, established players and will drive more outsourcing to its facilities.

Seekingalpha | 3 weeks ago
STERIS plc (STE) Q3 2026 Earnings Call Transcript

STERIS plc (STE) Q3 2026 Earnings Call Transcript

STERIS plc (STE) Q3 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago

Steris plc (2TG) FAQ

What is the stock price today?

The current price is €216.00.

On which exchange is it traded?

Steris plc is listed on XBER.

What is its stock symbol?

The ticker symbol is 2TG.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.08%.

What is its market cap?

As of today, the market cap is 21B.

When is the next earnings date?

The next earnings report will release on May 12, 2026.

Has Steris plc ever had a stock split?

Steris plc had 2 splits and the recent split was on Aug 25, 1998.

Steris plc Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Daniel A. Carestio CEO
XBER Exchange
IE00BFY8C754 ISIN
IE Country
18,000 Employees
17 Feb 2026 Last Dividend
25 Aug 1998 Last Split
1 Jun 1992 IPO Date

Overview

STERIS plc is a leading global provider of infection prevention products and services. With its operations spanning across four main segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental, STERIS caters to a wide range of needs in the medical and pharmaceutical fields. From offering cleaning chemistries and sterilization products to providing comprehensive equipment management and maintenance services, the company stands as a vital player in the mission to maintain sterility and prevent infection worldwide. Founded in 1985 and headquartered in Dublin, Ireland, STERIS has built a robust presence around the globe, servicing hospitals, healthcare providers, and pharmaceutical manufacturers with its innovative solutions and services.

Products and Services

  • Healthcare Segment

    Provides a variety of products and services essential for sterile processing departments and operating rooms. This includes cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, and lights, among other capital equipment. STERIS also offers comprehensive equipment management services, including installation, maintenance, upgrade, repair, and troubleshooting, as well as preventive maintenance programs, instrument, and endoscope repair and maintenance, and consulting for process improvement.

  • Applied Sterilization Technologies Segment

    Offers contract sterilization and testing services to medical device and pharmaceutical manufacturers. With around 50 contract sterilization and laboratory facilities, STERIS supports clients by ensuring their products meet strict sterility standards through a variety of sterilization methods.

  • Life Sciences Segment

    Focused on the design, manufacturing, and sale of consumable products like formulated cleaning chemistries, and equipment including sterility assurance products, sterilizers, and washer disinfectors. Similar to the Healthcare segment, the Life Sciences division provides equipment installation, maintenance, upgrade, and repair services, alongside preventive maintenance and repair services tailored for the life sciences industry.

  • Dental Segment

    Delivers a range of products for dental offices including hand and electric-powered dental instruments, infection control products, personal protective equipment, and water quality products. These offerings are aimed at enhancing infection prevention practices within the dental suite, ensuring safety and compliance in dental care operations.

Contact Information

Address: 70 Sir John Rogerson's Quay
Phone: 353 1 232 2000